Skip to content
ClinCalc Pro
Menu
Intravenous Iron

Iron Sucrose (Venofer) 100–200mg IV

Brand names: Venofer

Iron sucrose (Venofer) is an intravenous iron preparation widely used to treat iron deficiency anaemia in chronic kidney disease, particularly in haemodialysis patients, where oral iron is poorly absorbed or insufficient.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It supplies an iron-sucrose complex that is taken up by the reticuloendothelial system and incorporated into transferrin and ferritin, restoring iron available for haemoglobin synthesis.

Prescribing in practice

  • Give only where staff and equipment to treat anaphylaxis are immediately available, and observe the patient during and after administration for hypersensitivity.
  • Administer by slow intravenous injection or infusion, as rapid administration can cause hypotension.
  • Avoid in the first trimester of pregnancy and use later in pregnancy only when clearly necessary.

Monitoring

Monitor haemoglobin and iron indices to assess response and avoid iron overload, especially with repeated dialysis-unit dosing.

Counselling the patient

  • Tell staff at once about any rash, wheeze, dizziness or facial swelling during the injection.
  • Skin can stain if the drug leaks at the injection site, so report pain or burning there.
  • Several doses may be required to fully replenish your iron stores.

Evidence & guidelines

Renal anaemia guidance supports intravenous iron such as iron sucrose as first-line iron replacement in haemodialysis-dependent CKD.

Reference: KDIGO Anaemia in CKD Guidelines 2012; Venofer SPC; NICE NG203; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.